|
IL131709D0
|
|
Processes for preparing 1-butyl-2-[2'-(2H-tetrazol-5-yl) biphenyl-4-ylmethyl]-1H-indole-3- carboxylic acid
|
|
US6130220A
|
|
Sulfamide-metalloprotease inhibitors
|
|
US6083973A
|
|
Methods for inhibiting mucin secretion using RAR α selective antagonists
|
|
US6040446A
|
|
Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative
|
|
US6110937A
|
|
Phenoxymethyl piperidine derivatives for the treatment of neuropathic pain
|
|
MX9709559A
|
|
Method for the treatment of corticosteroid induced osteopenia.
|
|
US5958934A
|
|
Aryl pyrimidine derivatives and uses thereof
|
|
US5952331A
|
|
Aryl pyrimidine derivatives
|
|
AU4099497A
|
|
(S)-5,7-difluoro-1,2,3,4-tetrahydronaphthalen-2-ylamine and its preparation
|
|
HU9903376A3
|
|
Heteroaryl succinamides and their use as metalloproteinase inhibitors
|
|
US5891673A
|
|
Lck binding protein
|
|
US5872113A
|
|
Fluorinated vitamin D3 analogs
|
|
US6184349B1
|
|
Cloned peripheral nerve, tetrodotoxin-resistant sodium channel α-subunit
|
|
US6083953A
|
|
2- (2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3- propanediol derivative
|
|
US5688830A
|
|
Treatment of neuropathic pain
|
|
US5840890A
|
|
Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
|
|
WO9707815A2
|
|
Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis
|
|
WO9704010A1
|
|
SIGNAL TRANSDUCTION AGENTS OF T-CELL RECEPTOR Vα-1 GENE LOCUS
|
|
US5739336A
|
|
1,3,8-triaza- and 3,8-diaza-1-oxaspiro 4,5! decane derivatives
|
|
US5859014A
|
|
Pyrimidinedione, pyrimidinetrione, triazinedione and tetrahydroquinazolinedione derivatives as α1 -adrenergic receptor antagonists
|
